Clinical Trial Update: An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating intravenous golimumab in patients with active rheumatoid arthritis despite methotrexate therapy; results from the trial were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2013-10-14